Unlock instant, AI-driven research and patent intelligence for your innovation.

Polypeptide composition with special immune function, vaccine and application thereof

A technology of polypeptide composition and immune function, which is applied in the field of biomedicine and can solve problems that are not suitable for large-scale individuals

Inactive Publication Date: 2018-11-20
WNL生物医学科技有限公司 +1
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Epitope-specific short peptide vaccines use specific antigenic epitopes to ensure accurate CTL responses, which are limited by HLA specificity. Preliminary HLA typing is usually required before vaccination, which is not suitable for large-scale individuals

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide composition with special immune function, vaccine and application thereof
  • Polypeptide composition with special immune function, vaccine and application thereof
  • Polypeptide composition with special immune function, vaccine and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Example 1: Polypeptide composition combined with different Toll-like receptor ligands, or combined with aIL10R immunization

[0018] Experimental procedure:

[0019] C57BL / 6 mice were randomly divided into 4 groups, group 1 was EX+MPLA; group 2 was EX+MPLA+Rat IgG; group 3 was EX+MPLA+aIL10R; group 4 was PBS control group. The four groups of mice were subcutaneously immunized on the left abdomen, once a week, and immunized twice in total. The mice were sacrificed on the 6th day after the last immunization, and the inguinal draining lymph nodes were removed and photographed. The results showed that: 1. When EX+MPLA was used for immunization, the draining lymph nodes were significantly larger than that of the PBS control group, which indicated that the combination of EX and different Toll receptor ligands could enhance the immune response of the draining lymph nodes; 2. Using EX+MPLA+ When immunized with aIL10R, the draining lymph nodes were larger than those of the exp...

Embodiment 2

[0021] Example 2: Polypeptide composition combined with different Toll-like receptor ligands, or combined with aIL10R immunization

[0022] Experimental procedure:

[0023] C57BL / 6 mice were randomly divided into 4 groups, group 1 was EX+MPLA; group 2 was EX+MPLA+Rat IgG; group 3 was EX+MPLA+aIL10R; group 4 was PBS control group. The mice were subcutaneously immunized on the left side of the abdomen, once a week, and immunized twice in total. The mice were sacrificed on the 6th day after the last immunization, and the spleen was taken to prepare a single cell suspension, which was stimulated by the E7 epitope (the amino acid sequence of which was RAHYNIVTF), and the antigen-specific IFNγ+CD8+T cells were detected by enzyme-linked dot immunoassay. The results showed that: 1. When EX+MPLA was used for immunization, more specific IFNγ+CD8+T cells could be induced compared with PBS control group; The test group immunized with EX+MPLA+Rat IgG can induce a stronger IFNγ+CD8+ T cel...

Embodiment 3

[0025] Example 3: The combination of polypeptide composition and MPLA, combined with aIL10R immunization, preventive effect on HPV16E6 / E7 transformed mouse TC-1 tumor

[0026] Experimental procedure:

[0027] C57BL / 6 mice were randomly divided into 4 groups, namely EX+MPLA group, EX+MPLA+Rat IgG group, EX+MPLA+aIL10R group and PBS control group. The mice were subcutaneously immunized on the left hind legs, once a week, and immunized twice in total. On the 7th day after the second immunization, 2 × 10 5 A HPV16E6 / E7 transforms TC-1 tumor cells for attack. The tumor size was measured twice a week and the survival time of the mice was observed. Eighty days after immunization, the mice that survived the first TC-1 tumor inoculation challenge received the second TC-1 tumor inoculation challenge, and a new PBS control group was added. The tumor size was measured twice a week and the survival time of the mice was observed. The results show that: 1. On the 7th day after the EX+MP...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a polypeptide composition with a special immune function. The polypeptide composition comprises a human papilloma virus HPV16 type E7 protein full-length amino acid sequence and all epitopes which may stimulate antigen-specific cellular immunity. The polypeptide composition can be combined with a Toll-like receptor ligand and aIL10R to form a unique therapeutic vaccine which can induce cytotoxic lymphocytes and specifically kill HPV related tumor cells or HPV virus infected cells, so that the prepared vaccine has a potential therapeutical effect on HPV16 infected related benign or malignant diseases, for example, cervical cancer, cervical intraepithelial neoplasias, carcinoma of vulva, carcinoma of penis, anal carcinoma, oropharyngeal cancer and the like.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a polypeptide composition. Background technique [0002] Cervical cancer is one of the most common cancers in women, and the occurrence of cervical cancer and cervical intraepithelial neoplasia is closely related to persistent infection of human papillomavirus (HPV). The early proteins E6 and E7 encoded by HPV play an important role in the process of cell carcinogenesis and the maintenance of the malignant phenotype of cancer cells, and have become ideal targets for cervical cancer therapeutic vaccines. [0003] Currently there are a variety of therapeutic vaccines targeting target antigens E6 and E7. These vaccines induce cytotoxic T lymphocytes (cytotoxic T lymphocytes, CTLs) to specifically kill tumors or virus-infected cells without harming normal cells and become cervical cancer cells. Research hotspots in the field of immune prevention and control. Vaccine types include live ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/12A61K45/06A61K39/395A61P31/20A61P35/00
CPCA61K39/12A61K39/3955A61K45/06A61P31/20A61P35/00C12N2710/20034A61K2300/00
Inventor 刘晓松陈姝王跃建倪国颖王天放陈国强吴校连
Owner WNL生物医学科技有限公司